Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A population pharmacokinetic analysis of zanamivir in subjects with experimental and naturally occurring influenza: effects of formulation and route of administration.
Peng AW, Hussey EK, Moore KH. Peng AW, et al. J Clin Pharmacol. 2000 Mar;40(3):242-9. doi: 10.1177/00912700022008900. J Clin Pharmacol. 2000. PMID: 10709152 Clinical Trial.
The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1.
Moore KH, Barrett JE, Shaw S, Pakes GE, Churchus R, Kapoor A, Lloyd J, Barry MG, Back D. Moore KH, et al. AIDS. 1999 Nov 12;13(16):2239-50. doi: 10.1097/00002030-199911120-00006. AIDS. 1999. PMID: 10563709 Clinical Trial.
Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians.
Stein DS, Moore KH. Stein DS, et al. Pharmacotherapy. 2001 Jan;21(1):11-34. doi: 10.1592/phco. Pharmacotherapy. 2001. PMID: 11191730 Review.
Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.
Moore KH, Yuen GJ, Hussey EK, Pakes GE, Eron JJ Jr, Bartlett JA. Moore KH, et al. Antimicrob Agents Chemother. 1999 Dec;43(12):3025-9. doi: 10.1128/AAC.43.12.3025. Antimicrob Agents Chemother. 1999. PMID: 10582904 Free PMC article. Clinical Trial.
Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption.
Moore KH, Shaw S, Laurent AL, Lloyd P, Duncan B, Morris DM, O'Mara MJ, Pakes GE. Moore KH, et al. J Clin Pharmacol. 1999 Jun;39(6):593-605. doi: 10.1177/00912709922008209. J Clin Pharmacol. 1999. PMID: 10354963 Clinical Trial.
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole.
Moore KH, Yuen GJ, Raasch RH, Eron JJ, Martin D, Mydlow PK, Hussey EK. Moore KH, et al. Clin Pharmacol Ther. 1996 May;59(5):550-8. doi: 10.1016/S0009-9236(96)90183-6. Clin Pharmacol Ther. 1996. PMID: 8646826 Clinical Trial.
Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
Moore KH, Raasch RH, Brouwer KL, Opheim K, Cheeseman SH, Eyster E, Lemon SM, van der Horst CM. Moore KH, et al. Antimicrob Agents Chemother. 1995 Dec;39(12):2732-7. doi: 10.1128/aac.39.12.2732. Antimicrob Agents Chemother. 1995. PMID: 8593010 Free PMC article. Clinical Trial.
The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor GW420867X is unaffected by food in healthy male volunteers.
Cass LM, Moore KH, Dallow NS, Jones AE, Sisson JR, Prince WT. Cass LM, et al. J Clin Pharmacol. 2001 May;41(5):528-35. doi: 10.1177/00912700122010401. J Clin Pharmacol. 2001. PMID: 11361049 Clinical Trial.
169 results
Jump to page